QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
$62.60
+1.4%
$58.09
$50.72
$87.30
$31.41B0.776.10 million shs7.86 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$372.04
-1.4%
$379.31
$310.42
$415.73
$27.24B1.04510,148 shs444,740 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
+2.18%-1.31%+1.14%-9.46%-24.66%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.00%-2.62%-4.63%+10.04%+2.64%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
3.9529 of 5 stars
2.03.04.22.02.11.71.9
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.775 of 5 stars
2.45.01.73.22.62.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
1.93
Reduce$67.507.83% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.80
Moderate Buy$435.2016.98% Upside

Current Analyst Ratings

Latest WST and ADM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$63.00 ➝ $64.00
3/14/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$85.00 ➝ $74.00
3/13/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$70.00 ➝ $65.00
3/13/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$66.00 ➝ $60.00
2/16/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$400.00 ➝ $375.00
2/13/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$440.00 ➝ $470.00
2/7/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$323.00 ➝ $536.00
2/1/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$57.00
1/26/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$104.00 ➝ $51.00
1/23/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
1/22/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
$93.94B0.33$9.41 per share6.65$45.27 per share1.38
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.95B9.23$10.04 per share37.07$39.31 per share9.46

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
$3.48B$6.409.7810.81N/A3.71%15.25%6.76%4/30/2024 (Confirmed)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$593.40M$7.8847.2140.796.4520.12%21.60%16.26%4/25/2024 (Confirmed)

Latest WST and ADM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
$1.35N/A-$1.35N/AN/AN/A  
4/25/2024N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.31N/A-$1.31N/AN/AN/A  
3/12/2024Q4 23
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
$1.43$1.36-$0.07$1.66$23.79 billion$22.98 billion      
2/15/202412/31/2023
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.78$1.83+$0.05$1.83$740.43 million$732.00 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
$2.003.19%+7.72%31.25%52 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.800.22%+5.81%10.15%1 Years

Latest WST and ADM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.23%4/23/20244/24/20245/1/2024
1/25/2024
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
quarterly$0.503.89%2/7/20242/8/20242/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
0.34
1.60
0.95
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.03
2.88
2.24

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
78.28%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
1.20%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Archer-Daniels-Midland Company stock logo
ADM
Archer-Daniels-Midland
41,802501.76 million495.74 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60073.21 million72.82 millionOptionable

WST and ADM Headlines

SourceHeadline
Ex-Dividend Reminder: Lennar, Lowe’s And West PharmaceuticalEx-Dividend Reminder: Lennar, Lowe’s And West Pharmaceutical
forbes.com - April 19 at 10:24 AM
Ninety One UK Ltd Has $12.09 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)Ninety One UK Ltd Has $12.09 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 19 at 9:14 AM
Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging IndustryStrong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry
markets.businessinsider.com - April 18 at 1:51 PM
Ninety One North America Inc. Acquires 2,368 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Ninety One North America Inc. Acquires 2,368 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 18 at 1:33 PM
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
zacks.com - April 18 at 11:07 AM
West Pharmaceutical Services (WST) to Release Quarterly Earnings on ThursdayWest Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday
americanbankingnews.com - April 18 at 3:20 AM
Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. Increased by Zacks Research (NYSE:WST)Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. Increased by Zacks Research (NYSE:WST)
americanbankingnews.com - April 18 at 2:20 AM
Analysts Offer Predictions for West Pharmaceutical Services, Inc.s Q2 2024 Earnings (NYSE:WST)Analysts Offer Predictions for West Pharmaceutical Services, Inc.'s Q2 2024 Earnings (NYSE:WST)
marketbeat.com - April 17 at 4:48 PM
Heres Why We Think West Pharmaceutical Services, Inc.s (NYSE:WST) CEO Compensation Looks Fair for the time beingHere's Why We Think West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO Compensation Looks Fair for the time being
finance.yahoo.com - April 17 at 9:53 AM
Everence Capital Management Inc. Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)Everence Capital Management Inc. Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 17 at 9:33 AM
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio NowReasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
zacks.com - April 17 at 8:46 AM
Zacks Research Research Analysts Lower Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)Zacks Research Research Analysts Lower Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)
americanbankingnews.com - April 17 at 1:22 AM
Q1 2024 EPS Estimates for West Pharmaceutical Services, Inc. Reduced by Zacks Research (NYSE:WST)Q1 2024 EPS Estimates for West Pharmaceutical Services, Inc. Reduced by Zacks Research (NYSE:WST)
marketbeat.com - April 16 at 7:27 AM
West Pharmaceutical Services to Announce Q1 Results, Hosts Conference CallWest Pharmaceutical Services to Announce Q1 Results, Hosts Conference Call
msn.com - April 15 at 8:01 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by International Assets Investment Management LLCWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by International Assets Investment Management LLC
marketbeat.com - April 15 at 4:44 AM
Allspring Global Investments Holdings LLC Sells 55,358 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Allspring Global Investments Holdings LLC Sells 55,358 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 14 at 5:36 AM
West to Host First-Quarter 2024 Conference CallWest to Host First-Quarter 2024 Conference Call
prnewswire.com - April 11 at 6:00 AM
New York State Teachers Retirement System Sells 3,791 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)New York State Teachers Retirement System Sells 3,791 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 8 at 6:42 AM
Boston Trust Walden Corp Decreases Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Boston Trust Walden Corp Decreases Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 6 at 6:58 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Rating of "Moderate Buy" from BrokeragesWest Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Rating of "Moderate Buy" from Brokerages
marketbeat.com - April 6 at 2:43 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Riverbridge Partners LLCWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Riverbridge Partners LLC
marketbeat.com - April 5 at 12:49 AM
Carderock Capital Management Inc. Invests $4.59 Million in West Pharmaceutical Services, Inc. (NYSE:WST)Carderock Capital Management Inc. Invests $4.59 Million in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 4 at 6:58 AM
What Makes West Pharmaceutical Services (WST) an Attractive Bet?What Makes West Pharmaceutical Services (WST) an Attractive Bet?
finance.yahoo.com - April 1 at 11:00 AM
Raymond James & Associates Buys 5,564 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Raymond James & Associates Buys 5,564 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - March 31 at 4:23 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Archer-Daniels-Midland logo

Archer-Daniels-Midland

NYSE:ADM
Archer-Daniels-Midland Company engages in the procurement, transportation, storage, processing, and merchandising of agricultural commodities, ingredients, flavors, and solutions in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. It operates in three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The company originates, merchandises, stores, and transports agricultural raw materials, such as oilseeds and soft seeds. It also engages in the agricultural commodity and feed product import, export, and distribution; and various structured trade finance activities. In addition, the company offers soybean meal and oil; vegetable and salad oils and protein meals; ingredients for the food, feed, energy, and industrial customers; margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products. Further, it provides peanuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose; alcohol, and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal; distillers' grains; corn germ; and citric acids. Additionally, the company provides proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and food products. It also offers futures commission merchant; commodity brokerage services; cash margins and securities pledged to commodity exchange clearinghouse; and cash pledged as security under certain insurance arrangements. The company was founded in 1902 and is headquartered in Chicago, Illinois.
West Pharmaceutical Services logo

West Pharmaceutical Services

NYSE:WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.